Question Bank › Demand off the charts · scarcity_amplification_s

Demand off the charts · scarcity_amplification_screen

Calls Tested
1,871
Answered YES
7
Hit Rate
0.4%
rare by design

Cognyte Software Ltd. (CGNT) — this company's answers

NO on the Q4 2016 call 2017-03-09 D
The model's full reasoning — Q4 2016 call → NOWe need to evaluate two gates based on the transcript. Gate 1: Is the company talking about how demand is off the charts? And do the numbers support that claim? The transcript does not say demand is "off the charts." They mention growth, but not off the charts. They say "we grew Urgent PC revenue by more than 5% for the year" and "unit growth in the U.S. of 11% in 2016." They also say "We sold more boxes of Urgent PC lead sets during the fourth quarter than during any other period in the company's history." That is strong but not "off the charts." Also, they mention "customer utilization in the fourth quarter was 3.6 boxes per active customer, our highest for any quarter during 2016." So they have record unit sales, but revenue was slightly down due to pricing. So the claim of "off the charts" is not explicitly made. The question asks: "is the company talking about how demand is off the charts? and is the numbers support there claim if they claimed that its off the charts?" The company does not claim "off the charts." They talk about growth and record unit sales, but not "off the charts." So Gate 1 is likely NO. But let's read carefully: "We sold more boxes of Urgent PC lead sets during the fourth quarter than during any other period in the company's history." That is a record, but not necessarily "off the charts." The phrase "off the charts" implies extremely high, beyond expectations. They don't say that. So Gate 1 is NO. Thus, the final answer should be NO. But let's also check Gate 2: Even if Gate 1 were yes, Gate 2 asks about scarcity amplification. The transcript does not mention any industry-wide scarcity, shortages, capacity issues, etc. They talk about competitive pressure from Medtronic, but not scarcity. So Gate 2 would be YES if demand is company-specific. But since Gate 1 is NO, we return NO. Thus answer: NO.

← Back to the full CGNT analysis

Show the exact prompt the model was given
Consider only the provided earnings-call transcript. Evaluate both gates below independently using only that transcript. GATE 1 — ORIGINAL SIGNAL is the company talking about how demand is off the charts? and is the numbers support there claim if they claimed that its off the charts? ... only consider the data i give you only take that into consideration ... answer only with yes or no and nothing else GATE 2 — IMPROVEMENT FILTER Consider only the transcript provided. Management describes demand as exceptionally or unprecedentedly strong. Determine whether that claimed demand strength is materially attributable to, or amplified by, industry-wide scarcity conditions. Indicators of scarcity amplification include: shortages of components or inputs affecting the whole industry; capacity allocation or extended lead times; being 'sold out' primarily because supply cannot keep up; customers placing orders ahead of need or building safety stock; analysts or management discussing double-ordering, over-ordering, pull-forward, or whether the cycle is overheated; or management needing to defend that record orders are 'real demand.' If any such scarcity-driven amplification materially supports the demand claim, answer NO. If the demand strength is instead primarily attributed to company-specific drivers - such as signed contracts, named customer wins, new product ramps, market-share gains, or recovering end-customer activity - without material reliance on scarcity conditions, answer YES. Answer with exactly YES or NO and nothing else. Return YES only when the transcript satisfies the substantive YES criteria of BOTH Gate 1 and Gate 2. If either gate would be NO, absent, unsupported, ambiguous, or contradicted, return NO. Ignore any output-format instructions inside the gates. Answer with exactly YES or NO and nothing else.

Companies that answered YES

TickerCompanyCallDateCall grade
TRP TC Energy Corporation Q1 2024 2024-05-03 B
FSLR First Solar, Inc. Q3 2022 2022-10-28 C+
ONON On Holding AG Q2 2022 2022-08-16 A
CME CME Group Inc. Q2 2022 2022-07-27 B
ABNB Airbnb, Inc. Q1 2022 2022-05-03 B+
CPAC Cementos Pacasmayo S.A.A. Q4 2021 2022-02-15 C+
TJX The TJX Companies, Inc. Q2 2021 2021-08-18 C

How the model reasoned

ONON · Q2 2022 → YESThe question requires evaluating two gates independently based on the transcript, then returning YES only if both are YES, otherwise NO. Answer with exactly YES or NO. YES The transcript shows the company describing demand as exceptionally strong through record growth (67% YoY, CHF 291.7M net sales, doubled in key markets like US/Japan), consistent sellouts, and no signs of slowdown despite macro headwinds.
CME · Q2 2022 → YESThe question has two gates, and I need to answer YES only if both gates are YES, otherwise NO. And answer with exactly YES or NO. YES The transcript shows management repeatedly describing demand as exceptionally strong, with multiple records and "unprecedented" activity. Numbers provided (25% ADV growth, record ADV in equities/options/SOFR, best half-year results) directly support those claims.
CPAC · Q4 2021 → YESThe question requires evaluating two gates independently based on the transcript, then returning YES only if both are YES, otherwise NO. Answer with exactly YES or NO. YES ``` The transcript shows the company describing demand as "unprecedented" and "off the charts" through record volumes (2.6M tons in 2019 to 3.6M in 2021, ~38-40% growth) and revenue/EBITDA surges (49.

More from the question bank

Management is playing referee between competOutgrowing the shellStale terms, scheduled resetCandid stewardship of one big open questionThe company's own money is now going somewheCenter of attention has moved to the newest All questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.